281 related articles for article (PubMed ID: 15814245)
1. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
Salamat-Miller N; Johnston TP
Int J Pharm; 2005 Apr; 294(1-2):201-16. PubMed ID: 15814245
[TBL] [Abstract][Full Text] [Related]
2. Tight junction modulation and its relationship to drug delivery.
Salama NN; Eddington ND; Fasano A
Adv Drug Deliv Rev; 2006 Apr; 58(1):15-28. PubMed ID: 16517003
[TBL] [Abstract][Full Text] [Related]
3. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
4. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
5. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
Fasano A
Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
[TBL] [Abstract][Full Text] [Related]
6. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
7. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells.
Jewell C; Cusack S; Cashman KD
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):163-71. PubMed ID: 15664300
[TBL] [Abstract][Full Text] [Related]
8. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
[TBL] [Abstract][Full Text] [Related]
9. [Advances in study of novel absorption enhancers based on tight junctions].
Kang A; Liang Y; Hao HP; Xie L; Wang GJ
Yao Xue Xue Bao; 2007 Nov; 42(11):1122-8. PubMed ID: 18300465
[TBL] [Abstract][Full Text] [Related]
10. Spiral progression in the development of absorption enhancers based on the biology of tight junctions.
Kondoh M; Takahashi A; Yagi K
Adv Drug Deliv Rev; 2012 May; 64(6):515-22. PubMed ID: 21802464
[TBL] [Abstract][Full Text] [Related]
11. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
12. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide.
Everett RS; Vanhook MK; Barozzi N; Toth I; Johnson LG
Mol Pharmacol; 2006 Feb; 69(2):492-500. PubMed ID: 16288084
[TBL] [Abstract][Full Text] [Related]
13. Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.
des Rieux A; Fievez V; Momtaz M; Detrembleur C; Alonso-Sande M; Van Gelder J; Cauvin A; Schneider YJ; Préat V
J Control Release; 2007 Apr; 118(3):294-302. PubMed ID: 17292503
[TBL] [Abstract][Full Text] [Related]
14. Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs.
Maher S; Brayden DJ; Feighery L; McClean S
Crit Rev Ther Drug Carrier Syst; 2008; 25(2):117-68. PubMed ID: 18540837
[TBL] [Abstract][Full Text] [Related]
15. Increased permeability of intestinal epithelial monolayers mediated by electroporation.
Ghartey-Tagoe EB; Morgan JS; Neish AS; Prausnitz MR
J Control Release; 2005 Mar; 103(1):177-90. PubMed ID: 15710509
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal absorption of drugs through the digestive barrier].
Houin G; Woodley J
Ann Pharm Fr; 2002 Nov; 60(6):365-71. PubMed ID: 12514501
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum.
Nylander O; Sjöblom M
Acta Physiol (Oxf); 2007 Apr; 189(4):325-35. PubMed ID: 17367402
[TBL] [Abstract][Full Text] [Related]
18. Intestinal absorption of bioactive oligopeptides: paracellular transport and tight junction modulation.
Yu Z; Liu D; Wu C; Zhao W
Food Funct; 2024 Jun; 15(12):6274-6288. PubMed ID: 38787733
[TBL] [Abstract][Full Text] [Related]
19. Conjugated linoleic acid enhances transepithelial calcium transport in human intestinal-like Caco-2 cells: an insight into molecular changes.
Murphy EF; Jewell C; Hooiveld GJ; Muller M; Cashman KD
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):295-301. PubMed ID: 16650747
[TBL] [Abstract][Full Text] [Related]
20. [Physiology of intestinal absorption].
Brazier F; Delcenserie R; Dupas JL
Rev Prat; 2001 May; 51(9):945-52. PubMed ID: 11458607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
